Furiex Pharmaceuticals Given New $157.00 Price Target at Cowen and Company (FURX)

Share on StockTwits

Stock analysts at Cowen and Company boosted their price target on shares of Furiex Pharmaceuticals (NASDAQ:FURX) to $157.00 in a report issued on Wednesday, Stock Ratings Network.com reports. Cowen and Company’s target price indicates a potential upside of 43.08% from the stock’s previous close.

Shares of Furiex Pharmaceuticals (NASDAQ:FURX) traded up 0.46% on Wednesday, hitting $110.24. The stock had a trading volume of 86,796 shares. Furiex Pharmaceuticals has a one year low of $32.01 and a one year high of $121.97. The stock has a 50-day moving average of $49.53 and a 200-day moving average of $43.53. The company’s market cap is $1.143 billion.

Several other analysts have also recently commented on the stock. Analysts at Ladenburg Thalmann raised their price target on shares of Furiex Pharmaceuticals from $57.00 to $137.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Zacks downgraded shares of Furiex Pharmaceuticals from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, January 2nd. They now have a $48.90 price target on the stock. Finally, analysts at Zacks upgraded shares of Furiex Pharmaceuticals from an “underperform” rating to an “outperform” rating in a research note to investors on Tuesday, November 12th. They now have a $37.20 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $98.48.

Furiex Pharmaceuticals, Inc is a drug development collaboration company. The Company’s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Citigroup Profit Beats Estimates
Citigroup Profit Beats Estimates
Dubai to Open New Six Flags Park in 2017
Dubai to Open New Six Flags Park in 2017
Source: FBI Probe Herbalife Marketing
Source: FBI Probe Herbalife Marketing
Ikea Investing in Illinois Wind Farm
Ikea Investing in Illinois Wind Farm
Stocks in China and Hong Kong Jump on Cross Border Investment Plans
Stocks in China and Hong Kong Jump on Cross Border Investment Plans
Alcoa Shares Increase After Earnings Beat Estimates
Alcoa Shares Increase After Earnings Beat Estimates


Leave a Reply

 
 
© 2006-2014 Ticker Report. Google+. Subscribe